Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant01:25

Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant

In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area. This equation is...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Assessing Equality of Touch to Guide Targeted Implementation of Post-induction Surface Disinfection Cleaning and Augmentation With Ultraviolet-C Irradiation.

A&A practice·2026
Same author

The persistent nature of surgical site infections, what are we missing?

The Journal of hospital infection·2026
Same author

Age and Procedural Timing for Asymptomatic Severe Aortic Stenosis: Analysis From the EARLY TAVR Trial.

Circulation. Cardiovascular interventions·2026
Same author

Scalable Identification of Clinically Relevant Chronic Obstructive Pulmonary Disease Documents in Large-Scale Electronic Health Record Datasets With a Lightweight Natural Language Processing Model: Retrospective Cohort Study.

JMIR medical informatics·2026
Same author

Relationship of Distance to PCI Center With In-Hospital Mortality After STEMI: Insights From a Rural Regional STEMI Network.

Journal of the Society for Cardiovascular Angiography & Interventions·2026
Same author

Bridging evidence and practice: implementation science and bundled care strategies for fluid management in critically ill neonates.

Frontiers in medicine·2026

Related Experiment Videos

Serious renal dysfunction after percutaneous coronary interventions can be predicted.

Jeremiah R Brown1, James T DeVries, Winthrop D Piper

  • 1The Dartmouth Institute for Health Policy and Clinical Practice, Lebanon, NH, USA. jeremiah.brown@dartmouth.edu

American Heart Journal
|January 25, 2008
PubMed
Summary

A new prediction rule identifies patients at high risk for serious renal dysfunction (SRD) after percutaneous coronary intervention (PCI). This tool aids physicians in targeted interventions to mitigate SRD risks and improve patient outcomes.

Related Experiment Videos

Area of Science:

  • Cardiology
  • Nephrology
  • Medical Prediction Models

Background:

  • Existing prediction rules for contrast-induced nephropathy post-percutaneous coronary intervention (PCI) are limited.
  • There is a need for models predicting serious renal dysfunction (SRD) risk before PCI.
  • SRD includes new dialysis, significant creatinine increase (> or = 2.0 mg/dL absolute or > or = 50% increase).

Purpose of the Study:

  • To develop and validate a clinical prediction rule for pre-PCI patient-specific risk of SRD.
  • To identify preprocedural patient characteristics predictive of post-PCI SRD.
  • To assess the impact of SRD on inhospital mortality.

Main Methods:

  • Prospective data collection from 11,141 patients undergoing PCI (2003-2005).
  • Multivariate logistic regression to identify predictive patient characteristics.
  • Model discrimination assessed using bootstrap-validated C-Index (ROC curve); calibration tested with Hosmer-Lemeshow statistic.
  • Model validation on PCI procedures from 2006.

Main Results:

  • SRD occurred in 0.74% of patients, with 19.3% inhospital mortality compared to 0.9% without SRD.
  • The prediction model showed good discrimination (ROC 0.87, validated ROC 0.84).
  • Key predictors included preprocedural creatinine (37%), congestive heart failure (24%), and diabetes (15%).

Conclusions:

  • SRD after PCI, though infrequent, is linked to high inhospital mortality.
  • A robust, validated clinical prediction rule for high-risk SRD patients was developed.
  • This model can guide targeted interventions to reduce post-PCI SRD risk.